Abbott Reports Fourth-Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq drops as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
UBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call
February 1, 2016 8:33 AM ESTUBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following the company's 4Q earnings report. Street estimates suggested a lower 2016 outlook, driven by tougher FX in geographies where ABT has fewer natural hedges. However, the volume slowdown in oildriven economies like Venezuela took another dime or so out of the 2016 EPS... More
William Blair Downgrades Abbott Labs (ABT) to Market Perform
January 29, 2016 7:28 AM ESTWilliam Blair downgraded Abbott Labs (NYSE: ABT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $36.71 yesterday.
... MoreAbbott (ABT) Tops Q4 EPS by 1c, FY16 EPS Falls Short of Views
January 28, 2016 7:33 AM ESTAbbott (NYSE: ABT) reported Q4 EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.27 billion.
GUIDANCE:
Abbott sees FY2016 EPS of $2.10-$2.20, versus the consensus of $2.26.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More